GB/T 12715-1991
Abolished
T/CI 307-2024
Active
Group standards
T/CI 307-2024 The quality requirements for mesenchymal stem cells used for disease treatment
T/CI 307-2024 The quality requirements for mesenchymal stem cells used for disease treatment
Price:
$ 49.00
Basic Information
Standard Code:
T/CI 307-2024
Standard Type:
Group standards
Standard Status:
Active
is_force_gb:
no
CCS Name:
Medicine
ICS Name:
Biology, botany, and zoology
Publish Date:
2024-03-21
Implement Date:
2024-03-21
Pages:
15 pages
Scope
This document specifies the key biological properties, biological efficacy, safety, labeling, packaging, storage, transportation, and testing report requirements for human mesenchymal stem cells (MSCs) used in disease treatment, defines the indicators for high-quality MSCs, provides basic parameters for identifying whether MSCs have replicative senescence, and sets forth the basic quality requirements for MSCs used in specific indications. This document is applicable to the research, development, production, and clinical application of human mesenchymal stem cells and their products used in disease treatment.